The results of our retrospective pilot study showed that among patients with advanced NSCLC with wild-type or unknown EGFR/ALK status, kinless patients had a worse prognosis, similar to elderly patients, patients with distant metastases, and those with poor performance status, although many had started primary treatment for lung cancer. Here, ALK is linked to lung cancer.